These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37481138)

  • 21. Apoptosis pathways in neuroblastoma therapy.
    Fulda S; Debatin KM
    Cancer Lett; 2003 Jul; 197(1-2):131-5. PubMed ID: 12880972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
    Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
    Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bin1 is linked to metastatic potential and chemosensitivity in neuroblastoma.
    Zhong X; Hoelz DJ; Kumar HR; Sandoval JA; Rescorla FJ; Hickey RJ; Malkas LH
    Pediatr Blood Cancer; 2009 Sep; 53(3):332-7. PubMed ID: 19418541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.
    Patterson DM; Gao D; Trahan DN; Johnson BA; Ludwig A; Barbieri E; Chen Z; Diaz-Miron J; Vassilev L; Shohet JM; Kim ES
    Angiogenesis; 2011 Sep; 14(3):255-66. PubMed ID: 21484514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinome multigenic panel identified novel druggable EPHB4-V871I somatic variant in high-risk neuroblastoma.
    Andolfo I; Lasorsa VA; Manna F; Rosato BE; Formicola D; Iolascon A; Capasso M
    J Cell Mol Med; 2020 Jun; 24(11):6459-6471. PubMed ID: 32336043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse.
    Ferrandis E; Da Silva J; Riou G; Bénard I
    Cancer Res; 1994 Apr; 54(8):2256-61. PubMed ID: 8174136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Extracellular Vesicles in the Progression of Human Neuroblastoma.
    Marimpietri D; Airoldi I; Faini AC; Malavasi F; Morandi F
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The metastatic microenvironment: lung-derived factors control the viability of neuroblastoma lung metastasis.
    Maman S; Edry-Botzer L; Sagi-Assif O; Meshel T; Yuan W; Lu W; Witz IP
    Int J Cancer; 2013 Nov; 133(10):2296-306. PubMed ID: 23649556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma.
    Raguénez G; Mühlethaler-Mottet A; Meier R; Duros C; Bénard J; Gross N
    BMC Cancer; 2009 Mar; 9():97. PubMed ID: 19331667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent biologic and genetic advances in neuroblastoma: Implications for diagnostic, risk stratification, and treatment strategies.
    Newman EA; Nuchtern JG
    Semin Pediatr Surg; 2016 Oct; 25(5):257-264. PubMed ID: 27955728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD57(high) neuroblastoma cells have aggressive attributes ex situ and an undifferentiated phenotype in patients.
    Schlitter AM; Dorneburg C; Barth TF; Wahl J; Schulte JH; Brüderlein S; Debatin KM; Beltinger C
    PLoS One; 2012; 7(8):e42025. PubMed ID: 22900004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment.
    Garcia-Gerique L; García M; Garrido-Garcia A; Gómez-González S; Torrebadell M; Prada E; Pascual-Pasto G; Muñoz O; Perez-Jaume S; Lemos I; Salvador N; Vila-Ubach M; Doncel-Requena A; Suñol M; Carcaboso AM; Mora J; Lavarino C
    BMC Cancer; 2022 Jun; 22(1):669. PubMed ID: 35715791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes.
    Khan FH; Pandian V; Ramraj S; Natarajan M; Aravindan S; Herman TS; Aravindan N
    BMC Cancer; 2015 Jul; 15():514. PubMed ID: 26159519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How Do Telomere Abnormalities Regulate the Biology of Neuroblastoma?
    Akter J; Kamijo T
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ICAM-2 confers a non-metastatic phenotype in neuroblastoma cells by interaction with α-actinin.
    Feduska JM; Aller SG; Garcia PL; Cramer SL; Council LN; van Waardenburg RC; Yoon KJ
    Oncogene; 2015 Mar; 34(12):1553-62. PubMed ID: 24704826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ICAM-2 expression mediates a membrane-actin link, confers a nonmetastatic phenotype and reflects favorable tumor stage or histology in neuroblastoma.
    Yoon KJ; Phelps DA; Bush RA; Remack JS; Billups CA; Khoury JD
    PLoS One; 2008; 3(11):e3629. PubMed ID: 18978946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of bone marrow as a metastatic site of human neuroblastoma.
    Morandi F; Corrias MV; Pistoia V
    Ann N Y Acad Sci; 2015 Jan; 1335():23-31. PubMed ID: 25315505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Metastatic Mouse Model Identifies Genes That Regulate Neuroblastoma Metastasis.
    Seong BK; Fathers KE; Hallett R; Yung CK; Stein LD; Mouaaz S; Kee L; Hawkins CE; Irwin MS; Kaplan DR
    Cancer Res; 2017 Feb; 77(3):696-706. PubMed ID: 27899382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis.
    Sugiura Y; Ma L; Sun B; Shimada H; Laug WE; Seeger RC; DeClerck YA
    Cancer Res; 1999 Mar; 59(6):1327-36. PubMed ID: 10096567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal Stromal Cells in Neuroblastoma: Exploring Crosstalk and Therapeutic Implications.
    Hochheuser C; Windt LJ; Kunze NY; de Vos DL; Tytgat GAM; Voermans C; Timmerman I
    Stem Cells Dev; 2021 Jan; 30(2):59-78. PubMed ID: 33287630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.